First live targeting of tumors with RNA-based technology

Courtesy EurekAlert! - Cancer  Sun, 11/29/2009 - 23:00

(Duke University Medical Center) Researchers at Duke University Medical Center have devised a way they might deliver the right therapy directly to tumors using special molecules, called aptamers, which specifically bind to living tumor tissue.

They screened a large pool of aptamers in a rodent with liver cancer until they found the best molecule to bind to a tumor protein.

Tags:

 

More related items

Vaccines to boost immunity where it counts, not just...
(Duke University Medical Center) Researchers at Duke University Medical Center have created synthetic nanoparticles that target lymph nodes and greatly boost vaccine responses, said lead...

Serendipity contributes to MRSA susceptibility...
(Duke University Medical Center) Duke University Medical Center researchers have found two genes in mice which might help identify why some people are more susceptible than others to...

Statins associated with lower cancer recurrence...
(Duke University Medical Center) Men who use statins to lower their cholesterol are 30 percent less likely to see their prostate cancer come back after surgery compared to men who do not use...

Country Save HE Laundry Detergent, Powder, 160-Load,...

Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com